| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |